Chudobiński Cezary, Pasicz Katarzyna, Hanke Małgorzata, Kaczmarek Adam, Pajdziński Mateusz, Kołacińska-Wow Agnieszka, Gottwald Leszek, Kuncman Wojciech, Podgórski Michał, Cieszanowski Andrzej
Department of Radiology, Copernicus Memorial Hospital, 62 Pabianicka Str., 93-513 Lodz, Poland.
Medical Physics Department, The Maria Sklodowska-Curie National Research Institute of Oncology, 15/B Wawelska Str., 00-001 Warsaw, Poland.
Cancers (Basel). 2025 Jun 18;17(12):2030. doi: 10.3390/cancers17122030.
The evaluation of lymph nodes (LNs) in patients with suspected oncological disease is a crucial factor influencing further diagnostics and management. However, there is a lack of a dedicated system for the precise and comprehensive assessment of LNs. To address this gap, we developed the Lymph Node Reporting and Data System (LN-RADS).
This retrospective multiparametric analysis included the assessment of 719 LNs in 489 patients. The images were evaluated by three radiologists using the LN-RADS scale, assigning each case to one of six group: 1 (normal), 2 (steatotic), 3 (reactive), 4a (low suspicion of malignancy) vs. 4b (high suspicion of malignancy), and 5 (definitely malignant) and were then correlated with histopathological results. The diagnostic performance of LN-RADS was validated. The analysis of 12 morphological features of LNs was performed to identify predictors of malignancy.
Histopathological analysis confirmed 389 malignant and 330 benign LNs. LN-RADS achieved 89% sensitivity, 85% specificity, and 87% accuracy in the diagnosis of malignant LN. The observed risk of malignancy by group was 0% for LN-RADS 1, 0% for LN-RADS 2, 2% for LN-RADS 3, 31% for LN-RADS 4a, 77% for LN-RADS 4b, and 97% for LN-RADS 5. Cohen's kappa statistic indicated substantial inter-reader agreement. Among the evaluated features, the strongest predictor of malignancy was the cortex thickness diameter, with a threshold value of ≥6 mm (82% accuracy; AUC = 0.894).
This study demonstrated the high efficacy of the LN-RADS system in distinguishing between benign and malignant lymph nodes and in stratifying malignancy risk. It also showed substantial inter-rater agreement.
对疑似肿瘤疾病患者的淋巴结(LN)进行评估是影响进一步诊断和治疗的关键因素。然而,目前缺乏一个专门用于精确、全面评估淋巴结的系统。为了填补这一空白,我们开发了淋巴结报告和数据系统(LN-RADS)。
这项回顾性多参数分析包括对489例患者的719个淋巴结进行评估。三名放射科医生使用LN-RADS量表对图像进行评估,将每个病例分为六组之一:1组(正常)、2组(脂肪变性)、3组(反应性)、4a组(恶性可能性低)与4b组(恶性可能性高)以及5组(肯定为恶性),然后将其与组织病理学结果进行关联。对LN-RADS的诊断性能进行了验证。对淋巴结的12个形态学特征进行分析以确定恶性肿瘤的预测指标。
组织病理学分析证实389个淋巴结为恶性,330个为良性。LN-RADS在诊断恶性淋巴结方面的灵敏度为89%,特异度为85%,准确度为87%。各分组观察到的恶性风险为:LN-RADS 1组为0%,LN-RADS 2组为0%,LN-RADS 3组为2%,LN-RADS 4a组为31%,LN-RADS 4b组为77%,LN-RADS 5组为97%。Cohen's kappa统计量表明阅片者之间具有高度一致性。在评估的特征中,最强的恶性肿瘤预测指标是皮质厚度直径,阈值为≥6 mm(准确度82%;曲线下面积 = 0.894)。
本研究证明了LN-RADS系统在区分良性和恶性淋巴结以及对恶性风险进行分层方面具有很高的效能。它还显示出阅片者之间具有高度一致性。